Bunny Twiford, RN, president of Twiford Consulting in Warminster, Pa., shares six things GI-driven ASCs should benchmark. 1. Length of the procedure vs. scheduling allotments. Ms. Twiford says ASCs ...
Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built around it, is shifting fast. Here’s what five leaders have told ...
To prepare for your appointment, we encourage you to do the following: Fill out the registration forms below and bring them with you to your appointment. Review the patient instructions prior to your ...
Please provide your email address to receive an email when new articles are posted on . In response to safety concerns surrounding sedation for patients prescribed glucagon-like peptide-1 receptor ...
Please provide your email address to receive an email when new articles are posted on . As the effective date of UnitedHealthcare’s prior authorization policy for gastroenterology endoscopy services ...
A consensus on major and minor key performance indicators (KPIs) was established to improve the quality of upper gastrointestinal (GI) endoscopy and reduce post-endoscopy upper GI cancer. The adoption ...
Carbon dioxide insufflation has emerged as a pivotal technique in gastrointestinal endoscopy, offering significant advantages over conventional air insufflation. Owing to its rapid absorption and ...
- On track to submit a 510(k) to the U.S. FDA for the Pure-Vu Gen 4 Gastro device in Q4 2023 to support the 400,000 upper GI bleeds and other procedures with impaired visualization in the U.S.- - Pure ...
Doctors may perform an upper gastrointestinal endoscopy to diagnose and help treat stomach ulcers. During the procedure, a healthcare professional inserts an endoscope through the mouth and into the ...
New data from the Mayo Clinic provide added reassurance that the rate of pulmonary aspiration during upper gastrointestinal (GI) endoscopy is low in patients taking a glucagon-like peptide 1 (GLP-1) ...
Aspero Medical, a CU spin-out company co-founded by Professor Mark Rentschler, has received clearance from the Food and Drug Administration (FDA) to market and sell the Ancora-SB small bowel balloon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback